Direct-to-proteasome strategy degrades two cancer proteins and may curb drug resistance

The USP14/IU1-248 complex. Credit: Nature Communications (2026). DOI: 10.1038/s41467-026-71132-5

A preclinical study has developed a strategy that…

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *